Physician

Aleida Rodriguez

According to 2025 Medicare claims, Aleida Rodriguez (NPI: 1821433137) practices endocrinology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is SWEDISHAMERICAN HOSPITAL (NPI: 1962451732; TIN: 362222696) and primary practice location at 61107-5639.

Rodriguez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 281 traditional Medicare patients, billed 1,092 HCPCS/CPT codes, and received $35,565 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,391 prescription claims across 581 beneficiaries totaling $2,291,971 in drug costs, led by Trulicity (Dulaglutide). DME data shows 384 claims. Open Payments data shows 1 records totaling $150. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $7,878 to $35,565. Similarly, Part D prescription costs have moved sharply higher in recent years, from $27,905 to $2,291,971. For DME billing, reported payments moved sharply higher in recent years, from $15,211 to $107,770.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	72	139	$7,878
2017	61	100	$5,715
2018	N/R	N/R	N/R
2019	64	141	$8,551
2020	164	3,007	$49,353
2021	213	5,730	$80,336
2022	256	1,803	$59,744
2023	276	1,769	$51,501
2024	281	1,092	$35,565

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	272	$27,905
2016	38	265	$23,321
2017	21	56	$7,080
2018	17	46	$4,678
2019	49	147	$42,479
2020	168	1,242	$509,223
2021	257	2,068	$911,844
2022	385	3,256	$1,616,450
2023	505	4,598	$2,621,111
2024	581	5,391	$2,291,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	50	135	$13,198
2021	74	252	$31,110
2022	53	306	$46,032
2023	83	413	$68,547
2024	104	384	$107,511

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	42	42	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	238	$69
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	48	88	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	172	225	$12
36415	Insertion of needle into vein for collection of blood sample	87	127	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	365	13,302	$447,532
Jardiance	Empagliflozin	314	20,368	$398,003
Ozempic	Semaglutide	316	12,052	$389,052
Farxiga	Dapagliflozin Propanediol	115	6,580	$122,603
Rybelsus	Semaglutide	78	3,870	$122,308

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	58	259	$93,298
E0784	External ambulatory infusion pump, insulin	Y	N/R	16	$5,373
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	19	19	$3,975
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	13	$3,005
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$926

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$150	SANOFI-AVENTIS U.S. LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aleida Rodriguez?

Tedicare shows public-source Medicare data for Aleida Rodriguez (NPI 1821433137), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleida Rodriguez have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aleida Rodriguez?

Aleida Rodriguez is linked to SWEDISHAMERICAN HOSPITAL (billing NPI 1962451732) in the available physician profile data.

Does Aleida Rodriguez have Open Payments data?

Aleida Rodriguez has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.